Chemoinformaics analysis of 13-Heptadecyn-1-ol
| Molecular Weight | 252.442 | nRot | 12 |
| Heavy Atom Molecular Weight | 220.186 | nRig | 1 |
| Exact Molecular Weight | 252.245 | nRing | 0 |
| Solubility: LogS | -5.748 | nHRing | 0 |
| Solubility: LogP | 5.765 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 50.5294 |
| nHD | 1 | BPOL | 32.1026 |
| QED | 0.379 |
| Synth | 2.312 |
| Natural Product Likeliness | 0.879 |
| NR-PPAR-gamma | 0.238 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.017 |
| Pgp-sub | 0.002 |
| HIA | 0.007 |
| CACO-2 | -4.66 |
| MDCK | 0.0000123 |
| BBB | 0.599 |
| PPB | 0.971902 |
| VDSS | 1.78 |
| FU | 0.00967738 |
| CYP1A2-inh | 0.648 |
| CYP1A2-sub | 0.192 |
| CYP2c19-inh | 0.699 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.307 |
| CYP2c9-sub | 0.97 |
| CYP2d6-inh | 0.078 |
| CYP2d6-sub | 0.076 |
| CYP3a4-inh | 0.312 |
| CYP3a4-sub | 0.053 |
| CL | 6.784 |
| T12 | 0.253 |
| hERG | 0.134 |
| Ames | 0.005 |
| ROA | 0.017 |
| SkinSen | 0.96 |
| Carcinogencity | 0.061 |
| EI | 0.929 |
| Respiratory | 0.276 |
| NR-Aromatase | 0.237 |
| Antiviral | Yes |
| Prediction | 0.718361 |